ARCHIVES

Cancer Program Critic Epstein Invited To NCAB T Make Argument: “We’re Losing War In Cancer”

This article is from The Cancer Letter archive.

Vol. 18 No. 18 | May 1, 1992

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

NCCS Networker Volume 9 Issue 4, Winter 1995

January 12, 1995

DePinho’s Wife Was Briefed on AVEO Data 11 Days Before He Touted Stock on CNBC

September 13, 2013

Clinical Trials Approved By NCI CTEP Last Month

April 29, 2011

ASCO Proposes Principles For Future Debate on Medicaid

November 21, 2014

NCI To Voluntarily Spends $196 Million On Breast Cancer; Will Require Reallocation

November 13, 1992